Bionano Genomics (BNGO) Revenue & Revenue Breakdown
Bionano Genomics Revenue Highlights
Latest Revenue (Y)
$36.12M
Latest Revenue (Q)
$7.77M
Main Segment (Y)
Product
Main Geography (Y)
Americas
Bionano Genomics Revenue by Period
Bionano Genomics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $36.12M | 29.90% |
| 2022-12-31 | $27.80M | 54.62% |
| 2021-12-31 | $17.98M | 111.47% |
| 2020-12-31 | $8.50M | -16.06% |
| 2019-12-31 | $10.13M | -15.59% |
| 2018-12-31 | $12.00M | 26.26% |
| 2017-12-31 | $9.51M | 39.93% |
| 2016-12-31 | $6.79M | - |
Bionano Genomics generated $36.12M in revenue during NA 2023, up 29.90% compared to the previous quarter, and up 300.95% compared to the same period a year ago.
Bionano Genomics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $7.77M | -11.38% |
| 2024-03-31 | $8.77M | -18.21% |
| 2023-12-31 | $10.72M | 15.06% |
| 2023-09-30 | $9.32M | 7.57% |
| 2023-06-30 | $8.66M | 16.82% |
| 2023-03-31 | $7.42M | -9.74% |
| 2022-12-31 | $8.21M | 13.77% |
| 2022-09-30 | $7.22M | 8.26% |
| 2022-06-30 | $6.67M | 17.10% |
| 2022-03-31 | $5.70M | -9.62% |
| 2021-12-31 | $6.30M | 35.38% |
| 2021-09-30 | $4.66M | 20.72% |
| 2021-06-30 | $3.86M | 21.72% |
| 2021-03-31 | $3.17M | -20.59% |
| 2020-12-31 | $3.99M | 81.68% |
| 2020-09-30 | $2.20M | 85.79% |
| 2020-06-30 | $1.18M | 4.05% |
| 2020-03-31 | $1.14M | -59.27% |
| 2019-12-31 | $2.79M | -15.81% |
| 2019-09-30 | $3.31M | 52.35% |
| 2019-06-30 | $2.17M | 17.37% |
| 2019-03-31 | $1.85M | -53.84% |
| 2018-12-31 | $4.01M | 41.89% |
| 2018-09-30 | $2.83M | -16.56% |
| 2018-06-30 | $3.39M | 91.69% |
| 2018-03-31 | $1.77M | -37.84% |
| 2017-12-31 | $2.85M | 3.72% |
| 2017-09-30 | $2.74M | 24.91% |
| 2017-06-30 | $2.20M | 27.62% |
| 2017-03-31 | $1.72M | - |
Bionano Genomics generated $7.77M in revenue during Q2 2024, up -11.38% compared to the previous quarter, and up 104.80% compared to the same period a year ago.
Bionano Genomics Revenue Breakdown
Bionano Genomics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Product | $26.73M | $20.43M | $11.70M | $6.23M | $9.47M |
| Instrument Revenue | $10.00M | $8.57M | $5.89M | $3.08M | $6.76M |
| Software Revenue | $5.57M | $5.13M | - | - | - |
| Product and Service, Other | $9.39M | $700.00K | $600.00K | $2.27M | $655.06K |
| Consumable Revenue | $11.16M | $6.73M | $5.81M | $3.14M | $2.71M |
Bionano Genomics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (42.53%), Consumable Revenue (17.75%), Instrument Revenue (15.91%), Product and Service, Other (14.94%), and Software Revenue (8.86%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Software | $1.75M | $1.64M | $1.21M | $1.32M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Product | $6.83M | $8.21M | $6.46M | $6.61M | $5.45M | $9.79M | $3.61M | $3.91M | $3.12M | $3.85M | $3.30M | $2.50M | $2.05M | $2.73M | $1.58M | $940.00K | $983.00K | $2.60M | $3.16M | $2.02M |
| Product and Service, Other | $1.94M | $2.51M | $2.86M | $2.05M | $1.97M | $-1.57M | $3.62M | $2.76M | $2.58M | $2.45M | $1.35M | $1.36M | $1.12M | $1.26M | $616.00K | $242.00K | $153.00K | $184.94K | $150.72K | $154.24K |
| Instrument Revenue | $1.61M | $3.31M | $2.34M | $2.45M | $1.90M | $2.69M | $1.83M | $2.45M | $1.60M | $2.38M | $1.47M | $1.16M | $882.00K | $1.60M | $724.00K | $229.00K | $534.00K | - | - | - |
| Consumable Revenue | $3.46M | $3.49M | $2.48M | $2.95M | $2.23M | $1.97M | $1.78M | $1.47M | $1.52M | $1.47M | $1.83M | $1.34M | $1.17M | $1.13M | $856.00K | $711.00K | $449.00K | - | - | - |
Bionano Genomics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Product (43.78%), Consumable Revenue (22.21%), Product and Service, Other (12.44%), Software (11.22%), and Instrument Revenue (10.35%).
Bionano Genomics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Asia Pacific | $5.13M | $4.98M | $3.05M | $850.93K | $1.47M |
| EMEA | $12.96M | $8.96M | $5.60M | $3.16M | $3.63M |
| Americas | $18.02M | $13.86M | - | - | - |
| North America | - | - | $9.33M | $4.49M | $5.03M |
Bionano Genomics's latest annual revenue breakdown by geography, as of Dec 23: Americas (49.89%), EMEA (35.89%), and Asia Pacific (14.21%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMEA | $3.13M | $4.54M | $2.69M | $2.75M | $2.99M | $2.64M | $1.97M | $2.61M | $1.74M | $1.84M | $1.23M | $940.00K | $1.59M | $1.25M | $1.20M | $315.00K | $390.00K |
| Americas | $4.69M | $4.92M | $5.35M | $4.31M | $3.44M | - | - | - | - | - | - | - | - | - | - | - | - |
| Asia Pacific | $946.00K | $1.27M | $1.29M | $1.60M | $979.00K | $1.33M | $1.57M | $1.45M | $629.00K | $1.55M | $864.00K | $551.00K | $83.00K | $633.93K | $118.00K | $79.00K | $20.00K |
| North America | - | - | - | - | - | - | $3.68M | $2.61M | $3.33M | $2.91M | $2.56M | $2.37M | $1.50M | $2.10M | $874.00K | $788.00K | $726.00K |
Bionano Genomics's latest quarterly revenue breakdown by geography, as of Mar 24: Americas (53.48%), EMEA (35.73%), and Asia Pacific (10.79%).
Bionano Genomics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and | $19.37B | $4.99B |
| ISRG | Intuitive Surgical | $7.12B | $2.01B |
| RMD | ResMed | $4.69B | $1.20B |
| WST | West Pharmaceutical Services | $2.95B | $702.00M |
| NVST | Envista | $2.57B | $623.60M |
| MHUA | Meihua Medical | $97.10M | $48.91M |
| BNGO | Bionano Genomics | $36.12M | $7.77M |
| GMVD | G Medical Innovations | $4.42M | $-128.35K |
| NXGL | NEXGEL | $4.09M | $1.44M |
| POAI | Predictive Oncology | $1.78M | $419.65K |
| LUCY | Innovative Eyewear | $1.15M | $308.68M |
| STAA | STAAR Surgical | $322.42K | $77.36M |
| GCTK | GlucoTrack | - | - |
| MBOT | Microbot Medical | - | - |
| STSS | Sharps | - | - |
BNGO Revenue FAQ
What is Bionano Genomics’s yearly revenue?
Bionano Genomics's yearly revenue for 2023 was $36.12M, representing an increase of 29.90% compared to 2022. The company's yearly revenue for 2022 was $27.8M, representing an increase of 54.62% compared to 2021. BNGO's yearly revenue for 2021 was $17.98M, representing an increase of 111.47% compared to 2020.
What is Bionano Genomics’s quarterly revenue?
Bionano Genomics's quarterly revenue for Q2 2024 was $7.77M, a -11.38% decrease from the previous quarter (Q1 2024), and a -10.29% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $8.77M, a -18.21% decrease from the previous quarter (Q4 2023), and a 18.26% increase year-over-year (Q1 2023). BNGO's quarterly revenue for Q4 2023 was $10.72M, a 15.06% increase from the previous quarter (Q3 2023), and a 30.51% increase year-over-year (Q4 2022).
What is Bionano Genomics’s revenue growth rate?
Bionano Genomics's revenue growth rate for the last 3 years (2021-2023) was 100.86%, and for the last 5 years (2019-2023) was 256.54%.
What are Bionano Genomics’s revenue streams?
Bionano Genomics's revenue streams in c 23 are Product, Instrument Revenue, Software Revenue, Product and Service, Other, and Consumable Revenue. Product generated $26.73M in revenue, accounting 42.53% of the company's total revenue, up 30.85% year-over-year. Instrument Revenue generated $10M in revenue, accounting 15.91% of the company's total revenue, up 16.72% year-over-year. Software Revenue generated $5.57M in revenue, accounting 8.86% of the company's total revenue, up 8.66% year-over-year. Product and Service, Other generated $9.39M in revenue, accounting 14.94% of the company's total revenue, up 1241.29% year-over-year. Consumable Revenue generated $11.16M in revenue, accounting 17.75% of the company's total revenue, up 65.76% year-over-year.
What is Bionano Genomics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Bionano Genomics was Product. This segment made a revenue of $26.73M, representing 42.53% of the company's total revenue.